some level of cross-reactivity (Casals & Whitman, 1960) . Currently, recognized CVV subtypes include Tlacotalpan and Playas, identified in Mexico and Ecuador, respectively (Armstrong, Andreadis, & Anderson, 2015; Blitvich, Lorono-Pino, Garcia-Rejon, Farfan-Ale, & Dorman, 2012; Yang, Chan, et al., 2018) . Similar viruses, such as Maguari and Xingu, have been categorized as genomically distinct from CVV (Armstrong et al., 2015; Blitvich, Lorono-Pino, et al., 2012; Dunn, Pritlove, & Elliott, 1994; Groseth et al., 2017) . Reassortant Bunyamwera viruses have been isolated, including Cholul virus and Potosi virus; both of these reassortants are also categorized as distinct from CVV (Armstrong et al., 2015; Groseth et al., 2017) .
Cache Valley virus circulates in mosquitoes and mammals
throughout North America, Central America and parts of South America (Armstrong et al., 2015) . However, there have only been a small number of cases of human illness attributed to CVV infection (Wilson et al., 2017) . Most of the reports of mammalian pathology attributable to CVV infection in mammals describe infection in pregnant sheep and goats (McConnell, Livingston, Calisher, & Crandell, 1985; Rodrigues, 2011; Shapiro et al., 2012) . While CVV has been detected in multiple mosquito species, little research has investigated the epizootic cycle of CVV, or the relative importance of the major vectors responsible for transmission (Andreadis, Armstrong, Anderson, & Main, 2014; Ayers et al., 2018; Yang, Chan, et al., 2018) .
A scoping review (ScR) on CVV was prioritized to identify, characterize and summarize the available primary research on CVV, and to identify knowledge gaps. The ScR is a research synthesis methodology that aims to describe and map the research underpinning a broad research question or emerging research area in a reproducible and updateable manner (Peters et al., 2017) . Bias is minimized through a rigorous process and the use of a study protocol developed a priori.
To the best of our knowledge, a ScR on CVV has not previously been conducted.
| ME THODS

| ScR protocol and team
A study protocol was drafted a priori to document the rationale for the ScR and the search strategy, as suggested by Peters et al. (2017) .
The protocol also includes the appraisal tools and the analysis plan, which are provided in Appendix S1.
This manuscript conforms to the requirements of the PRISMA extension for ScRs (Tricco et al., 2018) . The ScR team included seven individuals with expertise in knowledge synthesis, vector-borne disease, zoonotic disease and library science.
| Research question
The research question was "What is the global evidence on CVV?"
The relevant context for the research question included the Impacts • Cache Valley virus (CVV) circulates in mosquito and animal species across a large area of North, Central and South America.
• The impact of CVV infection has only been extensively studied in small ruminants in the United States of America (USA) and Canada; foetal death or severe malformations may occur whether exposure occurs early in pregnancy.
• There are only six published records of human CVV-associated illness; however, serological studies indicate exposure may be common in some areas, in both humans and small ruminants.
F I G U R E 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram of the citations and articles throughout the scoping review process identification of all primary research from any settings ranging from insects and animals sampled in their natural environments, to species studied in laboratory settings, to in vitro studies of CVV. All populations which might potentially be sampled for demonstration of CVV or exposure to CVV were deemed relevant, including potential vectors, animal populations and human populations. were conducted, one using the original algorithm and one using ("cache valley" OR playas OR tlacotalpan) AND (virus) AND (outbreak); sequential hits were screened until hits were deemed irrelevant, in order to identify any additional grey literature reports. All potentially relevant citations not captured by the database search were added to the ScR.
| Search strategy
A search verification strategy was executed to ensure that all relevant publications were identified. Reference lists from 15 selected CVV literature reviews were hand searched for potentially relevant references missed by the electronic search. Additionally, 10 CVV primary research studies were identified as "key studies," and a search for studies citing these key studies was conducted in Google Scholar. Results were then cross-referenced with those captured by the database search, and any potentially relevant citation was added to the ScR. A complete list of the literature reviews and key studies included in the search verification is presented in the study protocol (Appendix S1). Search verification was stopped at the point of saturation, when no additional new references were identified.
| Relevance screening
Relevance screening, performed on the abstracts, titles and keywords of citations captured by the search, consisted of assessment of each citation with one question ("Does this citation describe primary research on CVV, or a predictive model examining the impacts of climate change on CVV") to rapidly identify potentially relevant research (Appendix S1). All citations describing primary research on CVV or CVV subtypes Tlacotalpan virus and Playas virus were deemed relevant and promoted to the next review level of data characterization, and the full article was procured.
| Study characterization
The second level of assessment, study characterization, was performed on full articles and captured data pertaining to the study focus, design, populations/samples and outcomes of the study. 1950 -1959 1 1960 -1969 20 1970 17 1980 25 1990 -1999 30 2000 -2009 17 2010 Study design a Observational 110
Prevalence 74
Cross-sectional 12
Surveillance or monitoring programme 12
Case-series or case report 7
Outbreak report 6
Case-control 2
Other 7 Experimental 48
Challenge trial 31
Molecular characterization 13
Controlled trial 1
Other 9
Evaluation of diagnostic tests 8 a Total may sum to more than 143 studies as some studies contributed to more than one category.
the data characterization level is presented in the data characterization tool (Appendix S1). 
| Data management and analysis
| RE SULTS
| General characteristics
Two hundred and seventy-four unique citations were screened at level one of the ScR for relevance, with 160 relevant studies promoted to second-level study characterization ( Figure 1 ). General characteristics of the 143 included relevant studies that were characterized in this ScR are described in Table 1 . Most of the research originated from North America (n = 126 studies) and was published in English (n = 142) in journals (n = 123). Only one Spanish study was excluded due to language of publication. Eight reports were classified as grey literature containing primary data and included government surveillance reports (n = 6) and laboratory reports (n = 2). Overall, a median of two (range 0-7) studies on CVV have been published annually since the first CVV investigation was published in 1959 (Table 1) .
The most common research focus was epidemiology (n = 104 studies), of which nine studies reported surveillance activities; multiple studies investigated more than one population category (e.g., included studies reported more than one focus of investigation (e.g., CVV prevalence survey with characterization of isolates recovered).
| Viral characteristics
Across 82 studies reporting on viral characteristics including genome and antigenicity of CVV, or CVV isolation, 108 different isolates of CVV were identified, as well as seven isolates of Tlacotalpan Based upon more recent phylogenetic analyses, some of the early isolates collected from South America have been reclassified primarily from CVV to Maguari; the original studies of these virus isolates indicated that they seemed antigenically indistinguishable (Casals & Whitman, 1960; Downs, Spence, Aitken, & Whitman, 1961 USA (6V-633) (Causey, Causey, Maroja, & Macedo, 1961; Holden & Hess, 1959) . CVV isolates BeAr 7272 and 6V-633 formed the basis of most antigenic testing in studies performed during the 1960s, with five studies from this period exclusively applying the Brazilian isolate (BeAr 7272) to analysis of samples from the USA (n = 3), Panama (n = 1) and Argentina (n = 1) Collins, 1965; Peralta, Shelokov, Vogel, & Longfellow, 1966; Sabattini, Shope, & Vanella, 1965; Work, 1964 (Groseth et al., 2017) .
Thus, the range of CVV and its subtypes may include all of North and
Central America as well as some northern areas of South America.
| Vectors of CVV
Findings of 52 observational studies sampling various mosquito species and 12 laboratory-based experiments of transmission and vector competence of selected mosquito species are presented in Table 2 .
Investigators sampled 146 wild-caught mosquito species (Appendix S4),
with 47 of 52 studies reporting CVV detection in at least one sample.
Eight laboratory-based studies examined mosquito species for competence as a vector of CVV (defined as the ability of a vector to be infected with, replicate and transmit CVV). Natural infection with CVV and con- Mosquito Coquillettidia venezuelensis has also been referred to as Mansonia venezuelensis in studies from the 1960s (Aitken & Spence, 1963; Peralta et al., 1966; Galindo, Srihongse, De Rodaniche, & Grayson,1966) .
d
The isolate in one study included in this data set (Peralta et al., 1966) was confirmed as CVV using two isolates TR20659 and BeAr 7272 now categorized as Maguari virus.
transmission study concluded that Cu. sonorensis is not a competent vector of CVV (Reeves & Miller, 2013) . 
| Non-human hosts of CVV
| CVV studies in sheep and goats
The impact of CVV on small ruminants has been the focus of most infection during pregnancy results in a range of negative birth outcomes from reproductive failure to major congenital defects. Eleven studies describing twelve challenge trials were conducted in the USA in sheep (n = 8 trials) and goats (n = 4) from 1969 to 2013, studying CVV pathogenesis (Appendix S3). Sixteen studies described the adverse foetal outcomes associated with CVV infection in small ruminants during early pregnancy (days 1-50 of gestation), the hallmark of which is a range of congenital defects of the skeletal and central nervous systems (Table 3) . Six studies reported pathology in sheep naturally infected with CVV (Appendix S3). One study estimated the interval of time between CVV exposure and development of viremia in sheep (Chung, Livingston, Jones, & Collisson, 1991) , with another describing the duration of viremia in CVV-infected goats (Kokernot, Radivojevic, & Anderson, 1969) .
Five outbreaks of clinical disease caused by CVV infection in sheep populations were described in six papers, occurring in the USA (in Texas, 1986 -1988 and North Dakota, 1990 ) and in Canada (in Ontario, during 2011 and 2016, and Québec, 2013) (Appendix S3).
These outbreaks were reported between the months of December 
| CVV studies in other non-human hosts
Seroprevalence of CVV was investigated in 33 studies sampling deer, rabbits, horses, swine, cows, foxes, dogs, raccoons, woodchucks, rats, voles, mules, wild birds, chickens, mongooses and monkeys McLean, Calisher, & Parham, 1987) . A study conducted in Maryland reported 45% of cattle sampled developed CVV neutralizing antibodies over a 6-month study period (Yuill, Gochenour, Lucas, Collins, & Buescher, 1970 ). An association between increasing age and odds of CVV seropositivity was reported in studies sampling white-tailed deer (n = 2 studies), horses (n = 1) and swine (n = 1) (Blackmore, 
TA B L E 4 (Continued)
1996; McLean et al., 1987; Neitzel & Grimstad, 1991) .
Challenge experiments (n = 15) were conducted in cows, guinea pigs, opossums, horses, chickens, hamsters, mice, deer, rabbits, raccoons and swine (Appendix S6). Most of these studies investigated the pathogenesis of CVV in animals (12/15) and/or the transmission of CVV to and from competent vectors (9/15). Researchers also evaluated the influence of vitamin A on the immune response to CVV in deer (Blackmore, 1996) . Only one study reported pathology (failure to litter in mice) resulting from CVV infection in an animal host other than sheep or goats (Nowicki, 1996) . Several aspects of experimentally induced CVV infection were described, including time of onset of CVV viremia post-exposure in rabbits, swine, goats and calves (Blackmore & Grimstad, 2008; Kokernot et al., 1969) and duration of viremia in deer, hamsters, mice, guinea pigs, rabbits and calves Edwards, Higgs, & Beaty, 1998; Kokernot et al., 1969) . White-tailed deer were identified as a potential reservoir for CVV, with reservoir defined as a population in which CVV naturally persists ).
| Transmission of CVV
Fourteen studies reported investigation of one or more broad aspects of CVV transmission, including vector-to-host transmission (n = 6 studies), host-to-vector transmission (n = 3), vector-to-vector transovarial only transmission (n = 3) and host-to-host transmission (n = 2). Four studies investigated more than one mode of transmission (Blackmore, (Table 5 ). In one study, eastern cottontails (Sylvilagus floridanus) were successfully infected by Co. perturbans but did not experience sufficient viremia to transmit CVV back to the mosquito (Blackmore & Grimstad, 2008) . In contrast, CVV transmission from hosts to mosquitoes was successful in studies using Syrian hamsters (n = 1) and mice (n = 3) ( Table 5 ). One study demonstrated an interaction between detectable CVV infection in mice following a challenge and exposure to mosquitoes (Edwards et al., 1998) . Eight studies investigated determinants of vector competence such as dose, extrinsic incubation period, infection rate, dissemination rate and transmission rate under experimental conditions (Aitken & Spence, 1963; Ayers et al., 2018; Miller, 1997; Reeves & Miller, 2013; Saliba et al., 1973; Yang, Chan, et al., 2018; Yuill & Thompson, 1970) .
Successful transovarial transmission of CVV in Cu. inornata was reported in one study (Corner et al., 1980) . However, unsuccessful transovarial CVV transmission attempts were reported in Ae. albopictus and Culex fatigans species, two species categorized to have limited competence as vectors of CVV (Table 5 ). In hosts, vertical transmission of CVV was demonstrated in mice, but adults did not become infected from the consumption of viremic pups and other contaminated bodily fluids (Blackmore, 1996; Edwards & Hendricks, 1997; Nowicki, 1996) .
| CVV studies in humans
Six human clinical cases of CVV were captured by this ScR; all attributed to CVV exposure occurring in the USA. The first case was reported in 1995 in North Carolina (CDC, 1996; Sexton et al., 1997) , followed by single cases occurring in Wisconsin in 2003 (Campbell et al., 2006) , New York in 2011 (CDC, 2012; Nguyen et al., 2013) and
Missouri 2015 (CDC, 2017) . More recently, in 2016 two immune-compromised men from New York and Australia, the latter with travel history to the USA, were diagnosed with CVV-associated meningoencephalitis (Wilson et al., 2017; Yang, Qiu, et al., 2018b) . Researchers hypothesized that the Australian patient's exposure likely occurred in 2013, but the diagnosis of CVV infection did not occur until 2016 after several years of chronic neurological deficits, eventually diagnosed as chronic meningoencephalitis (Wilson et al., 2017) . The clinical pathology of these severe human CVV cases was reported in journal articles, except for the Missouri case, which was only described in a surveillance report with limited case information (CDC, 2017) . (1/3) and motor control deficits (1/3) (Campbell et al., 2006; Nguyen et al., 2013; Sexton et al., 1997) . The Australian patient eventually diagnosed with CVV chronic meningoencephalitis displayed 6 months of progressive memory decline, slowing of speech and mood disturbance, predominantly anxiety; the diagnosis was made via metagenomic next-generation sequencing of the patient's cerebrospinal fluid and brain biopsy tissue (Wilson et al., 2017) . CVV illness was ultimately fatal, either directly or due to other complications, in three of five CVV cases for which outcome data were reported (Sexton et al., 1997; Wilson et al., 2017; Yang, Qiu, et al., 2018b) .
Symptoms of CVV infection
Twenty human CVV serosurveys conducted in North and South
America, reported human CVV seroprevalence ranging from 0% to 50%, in studies published from 1956 to 2010 (Table 6 ). As with non-human animal hosts, increasing age was associated with increasing odds of seropositivity in some studies (Blitvich, Saiyasombat, Talavera-Aguilar, et al., 2012; Heard, 1997) . Two case-control studies investigated the potential association between the presence of maternal CVV antibodies and congenital malformations in their babies.
While one study did not detect any CVV antibodies in the sample population (Edwards & Hendricks, 1997) , the second case-control study had a very small sample size, but did report a significant association between CVV antibodies in mothers and the occurrence of macrocephaly or microcephaly in their newborns (Calisher & Sever, 1995) .
| Diagnostic test performance
Eight studies assessed the performance of diagnostic tests for the detection of viral RNA or serological evidence of prior CVV infection. The majority of these papers described initial proof-ofaccuracy studies, using CVV-spiked samples at various dilutions and in various media to evaluate the sensitivity of the test; they also employed an array of other viruses to assess test specificity.
Among these eight studies, samples used included pooled mosquitoes (n = 2/8 studies), and animal (n = 1/8) or human (n = 1/8) sera.
We also captured in vitro experiments (n = 5/8). The captured diagnostic test studies investigated the performance of molecular (n = 5/8) and immunological (n = 3/8) assays, as well as virus isolation techniques (n = 1/8). All five molecular assays were reversetranscription polymerase chain reaction tests (Appendix S3).
Reported performance parameters included analytical sensitivity Nowicki (1996) a Some studies investigated more than one mode of transmission Blackmore & Grimstad, 2008; Corner et al., 1980; Saliba et al., 1973) . b Species or strain name not specified. c Isolate TR 20659 was isolated in Trinidad 1958 and was originally classified as CVV but is now considered to be indistinguishable from BeAR7272
which is a Maguari virus isolate (Downs et al., 1961; Groseth et al., 2017) . The antigenic test employed was developed using isolate BeAr 7272 Work, 1964) , TR 20659 (Downs et al., 1961) and CbaAr-426 (Sabattini et al., 1965) , which have been reclassified as Maguari virus (Groseth et al., 2017) . CVV and Maguari virus isolates were shown to be indistinguishable antigenically at the time of these studies (Casals & Whitman, 1960 TA B L E 6 (Continued) (n = 2 studies), specificity (n = 3) and limits of detection (n = 2).
One study investigated both immunological and molecular tests (Brockus,2000) .
| D ISCUSS I ON
The literature captured in this ScR describes a relatively small, but ongoing area of viral research. Serosurveys of mammals have yielded evidence of CVV exposure in domestic and wild animals across the Americas. The interpretation of the chronologically older surveys is complicated by the relative lack of diagnostic specificity of earlier assays, which could have led to some misclassification of samples (Drebot, 2015) . The relatively widespread evidence of CVV exposure in mammals, and detection in a variety of mosquito species across the Americas, makes the very small number of reported cases of clinical illness attributable to CVV infection striking.
Outbreaks of congenital anomalies in lambs born to CVV-infected dams were reported in the USA in the late 1980s (Chung et al., 1991; Edwards et al., 1988 (Wilson et al., 2017; Yang, Qiu, et al., 2018b) .
In Canada, ongoing "lookbacks" at suspect West Nile virus patients have revealed that some of these subjects have serological markers of CVV exposure, further supporting the possibility that under-diagnosis of CVV in human encephalitis or meningitis patients may occur (Dimitrova et al., 2011) . Similarly, the potential impact of CVV infection during pregnancy, currently recognized only in small ruminants, merits further research in other species, given the very small number of studies investigating CVV during pregnancy in humans and mice (Blackmore, 1996; Calisher & Sever, 1995; Edwards & Hendricks, 1997; Nowicki, 1996) .
Subgroups, or complexes, within the Bunyamwera serogroup have been proposed, and these subgroups are correlated with the geographic location where the viruses were isolated (Hunt & Calisher, 1979) . Based on the most recent phylogenetic analyses, CVV has been identified as being most closely related to Maguari and Fort Sherman viruses, with Tlacotalpan and Playas classified as subtypes of CVV (Armstrong et al., 2015; Blitvich, Lorono-Pino, et al., 2012; Yang, Chan, et al., 2018) . The relationship between CVV and these closely related viruses is complex, and overtime has resulted in the reclassification of several isolates; for example, BeAr 7272 and CbaAr-426, originally categorized as CVV, have been reclassified as Maguari or Bunyamwera virus isolates (Groseth et al., 2017) .
Reports of recent phylogenetic analyses conclude that some genetic diversity has been reported across CVV strains, but overall CVV is a well-conserved virus across geography and several decades (Armstrong et al., 2015; Blitvich, Lorono-Pino, et al., 2012; Groseth et al., 2017) . The emergence of a new CVV lineage in Connecticut, more closely related genomically to CVV strains from Mexico than to other locations in the United States, suggests a possible importation event of a novel CVV strain to a new location (Armstrong et al., 2015) . Therefore, the potential exists for future introductions of relatively novel CVV strains into new geographic areas, whether fortuitously in association with human activity, or as the geographic range of vectors expands.
Recent genomic analyses identified that different segments of the viral genome are conserved across similar, but distinct viruses, which explains the antigenic similarities and differences identified between viruses using different antigen-based methods of viral characterization (Groseth et al., 2017) . One implication of this finding is that distinguishing between viruses within the Orthobunyavirus genus may be difficult with antigenic tests, and even molecular tests need to be comprehensive enough (e.g., target several discerning segments of the viral genome) to distinguish between closely related viruses and any reassortments that may occur (Blitvich, Lorono-Pino, et al., 2012; Groseth et al., 2017) . Thus, CVV serological testing across studies may not have distinguished between some distinct, but related viruses, particularly in the early CVV studies from the 1950s and 1960s. Given the evidence for the current geographic distribution of CVV, it is likely that some CVV-positive serological results in the southern areas of South America were detecting exposure to closely related viruses such as Maguari virus (Casals & Whitman, 1960; Peralta et al., 1966; Sabattini et al., 1965) . Also, considering the virus' geography, studies conducted in North America in which the antigenic test was developed with a Maguari virus isolate likely represent exposure to CVV rather than Maguari Work, 1964) . Across studies presenting serological results, some misclassification of CVV exposure may have occurred with an unknown direction and magnitude, and this contributes some uncertainty about the estimates from these studies.
While we tried to conduct an exhaustive literature search, it is possible that some relevant research may have been missed, especially if it were only reported in grey literature such as producer updates. However, we feel that the potential for language bias in this ScR was low since only one potentially relevant Spanish paper was excluded due to language of publication.
Several knowledge gaps were identified by our ScR, including evidence characterizing the CVV epizootic cycle through studies that identified important vectors and mammalian reservoirs. The factors associated with increased prevalence of circulating CVV in major vectors or reservoirs are unclear. The prevalence of CVV exposure in humans in the Americas in the general population, or within targeted patient groups such as encephalitis patients, lacks representative evidence and therefore also remains somewhat unclear.
Future directions for CVV research therefore include several topic areas. Continued improvement in assays for evidence of CVV exposure, for example, in the area of specificity, that is the correct categorization of samples truly not exposed to CVV, would 
| CON CLUS IONS
Centers for Disease Control circulates in numerous mosquito and animal species across a large area from North to South America.
However, clinical disease caused by CVV infection has only been extensively studied in small ruminants in the USA and Canada.
Published reports of human disease attributable to CVV infection describe six severe cases; however, CVV-associated illness is likely under-reported or misdiagnosed. Future research should focus on characterizing the impact of CVV infection in human and animal populations.
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